Generation of <i>Slc35a3</i>^–/–mice using genome editing. by Soichiro Saito (15285875)

Subjects:

<i>Slc35a3</i> mRNA was expressed in the presomitic mesoderm during somite formation. by Soichiro Saito (15285875)

Subjects:

HPLC profiles of the heparinase digests of GAG-peptide preparations from the spine and limbs. by Soichiro Saito (15285875)

Subjects:

HPLC profiles of the chondroitinase digests of GAG-peptide preparations from the spine and limbs. by Soichiro Saito (15285875)

Subjects:

Glycosaminoglycan (GAG) synthesis is impaired in the spine and limbs of <i>Slc35a3</i>^{<i>–/–</i>}mice. by Soichiro Saito (15285875)

Subjects:

HPLC profiles of the keratanase digests of GAG-peptide preparations from the spine. by Soichiro Saito (15285875)

Subjects:

Disaccharide composition of chondroitin sulfate/dermatan sulfate (CS/DS) in the spine and limb. by Soichiro Saito (15285875)

Subjects:

Proliferation, apoptosis, and differentiation are not affected in <i>Slc35a3</i>^{<i>−/−</i>} chondrocytes. by Soichiro Saito (15285875)

Subjects:

Disaccharide composition of keratan sulfate (KS) disaccharides in the spine and limb. by Soichiro Saito (15285875)

Subjects:

Skeletal abnormalities in <i>Slc35a3</i>^{<i>–/–</i>}mice. by Soichiro Saito (15285875)

Subjects:

Heparanase activity in murine (A) and human (B) sepsis. by Lukas Martin (747245)

Appendix A. Details of the papers used as basic data. by Victoria Werenkraut (709129)

Heparanase level in murine (A) and human (B) sepsis. by Lukas Martin (747245)

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

“…Here, we discovered a 1<i>H</i>-1,2,3-triazole derivative <b>HP661</b> as a highly potent and orally available OXPHOS inhibitor that effectively blocked the activity of mitochondrial complex I. …”

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

“…Here, we discovered a 1<i>H</i>-1,2,3-triazole derivative <b>HP661</b> as a highly potent and orally available OXPHOS inhibitor that effectively blocked the activity of mitochondrial complex I. …”

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

“…Here, we discovered a 1<i>H</i>-1,2,3-triazole derivative <b>HP661</b> as a highly potent and orally available OXPHOS inhibitor that effectively blocked the activity of mitochondrial complex I. …”

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

“…Here, we discovered a 1<i>H</i>-1,2,3-triazole derivative <b>HP661</b> as a highly potent and orally available OXPHOS inhibitor that effectively blocked the activity of mitochondrial complex I. …”

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

“…Here, we discovered a 1<i>H</i>-1,2,3-triazole derivative <b>HP661</b> as a highly potent and orally available OXPHOS inhibitor that effectively blocked the activity of mitochondrial complex I. …”

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

“…Here, we discovered a 1<i>H</i>-1,2,3-triazole derivative <b>HP661</b> as a highly potent and orally available OXPHOS inhibitor that effectively blocked the activity of mitochondrial complex I. …”

<b><i>Agaricus bisporus</i></b><b> mushrooms are supplied with water through both apoplastic as well as symplastic routes from distinct substrate layers</b> by Koen C. Herman (20386205)